Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Transitional Cell 14Urinary Bladder Neoplasms 13Colorectal Neoplasms 10Carcinoma, Merkel Cell 9Breast Neoplasms 9Carcinoma, Renal Cell 7Neoplasms 6Neoplasm Metastasis 6Carcinoma, Non-Small-Cell Lung 6Small Cell Lung Carcinoma 4Carcinoma, Hepatocellular 4Turcot syndrome 3Stomach Neoplasms 3Neuroendocrine Tumors 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Urethral Neoplasms 2Ureteral Neoplasms 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Penile Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Neuroendocrine 2Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 5Nivolumab 4Cisplatin 4Paclitaxel 3Ifosfamide 3avelumab 2aldesleukin 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Ipilimumab 2vinflunine 1toripalimab 1rocakinogene sifuplasmid 1niraparib 1nimotuzumab 1lenvatinib 1fludarabine phosphate 1fludarabine 1enfortumab vedotin 1durvalumab 1dostarlimab 1dacomitinib 1cemiplimab 1cabozantinib 1cabazitaxel 1Vorinostat 1VGX-3100 1Specimen Handling 1Ritonavir 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Penile Neoplasms × avelumab × Clear all
NCT03391479 2025-12-18

A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy

University Health Network, Toronto

Phase 2 Active not recruiting
25 enrolled
Genitourinary

Neoplasm Metastasis, Penile Neoplasms

NCT03774901 2023-04-21

PULSE

Centre Hospitalier Universitaire de Besancon

Phase 2 Unknown
32 enrolled
Genitourinary

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡